Diligence memo · auto-generated · as of July 2, 2026

AF Life Sciences, Inc.

AF Life Sciences, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

AF Life Sciences, Inc. operates in Manufacturing, based in DENVER.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

AF Life Sciences, Inc. has raised $490K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $490K on 2021-08-12.

Most recent recorded round closed around 2021-08-12.

Valuation (modeled)modeled

Provath models AF Life Sciences, Inc. at approximately $5.0M (range $333K–$40M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.00× the median modeled value of Pre-Seed Manufacturing companies in 2019–2021 (171 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 4.9 yr ago; this sector typically re-raises about every 12 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 21% of Manufacturing peers (3257 compared).

Modeled value ranks above 31% of those peers.

Closest niche peers: Surfx Technologies LLV, Pioneer Botanicals, LLC, Target Arm LLC, OVCBC Enterprises Inc., Optical Structures Inc.

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.